3 terminated, 2 active not recruiting. 5 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Active not recruiting 2 |
| Phase 1 | 4 | Active not recruiting 2, Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow rivogenlecleucel: new trials by email Literature Review of rivogenlecleucel trials Research Report on rivogenlecleucel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS rivogenlecleucel, rimiducid, Cyclophosphamide - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 / Phase 3 | Terminated | Bellicum Pharmaceuticals | 1 | 2018-12-27 | 2023-09-29 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2017-01-01 | 2023-09-26 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Active not recruiting | Bellicum Pharmaceuticals | 120 | 2014-04-01 | 2022-07-12 |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2014-04-01 | 2023-09-29 |
| Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant BPX-501 dose 1, Rimiducid, BPX-501 dose 2 - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1 / Phase 2 | Active not recruiting | Bellicum Pharmaceuticals | 36 | 2013-03-01 | 2022-07-12 |
Leukemia, Myeloid, Acute (5) · Myelodysplastic Syndromes (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Anemia, Aplastic (3) · Cytopenia (3) · Hematologic Neoplasms (3) · Leukemia (3) · Lymphoma, Non-Hodgkin (3) · Primary Immunodeficiency Diseases (3) · Anemia (2) · Anemia, Diamond-Blackfan (2) · Anemia, Sickle Cell (2) · Fanconi Anemia (2) · Hemoglobinopathies (2) · Osteopetrosis (2)
United States (3) · Italy (2) · United Kingdom (1)